|
Real-time Estimate
Tradegate
00:34:22 13/08/2026 HKT
|
5-day change | 1st Jan Change | ||
| 21.80 EUR | -3.77% |
|
-3.59% | +3.48% |
| 08:55pm | A No to BMS can open doors for a Yes to GSK |  |
| 06:02pm | Trump's goal to split MMR vaccine could take a decade, experts say | RE |
| Market Cap | 75.97B 103B 88.9B 83.29B 143B 9,787B 145B 980B 383B 4,900B 385B 377B 16,340B | P/E 2026 * |
14.1x | P/E 2027 * | 11.6x |
|---|---|---|---|---|---|
| Enterprise Value | 95.05B 128B 111B 104B 179B 12,245B 181B 1,226B 479B 6,131B 482B 472B 20,444B | EV / Sales 2026 * |
2.8x | EV / Sales 2027 * | 2.59x |
| Free-Float |
92.75% | Yield 2026 * |
3.67% | Yield 2027 * | 3.95% |
Last Transcript: GSK plc
| 1 day | -3.99% | ||
| 1 week | -3.59% | ||
| Current month | -2.86% | ||
| 1 month | -4.23% | ||
| 3 months | +0.18% | ||
| 6 months | -12.48% | ||
| Current year | +3.48% |
| 1 week | 21.73 |  | 22.89 |
| 1 month | 21.73 | | 23.61 |
| Current year | 20.27 | | 26.02 |
| 1 year | 16.26 | | 26.02 |
| 3 years | 14.68 | | 26.02 |
| 5 years | 14.62 | | 27.13 |
| 10 years | 14.62 | | 27.52 |
| Manager | Title | Age | Since |
|---|---|---|---|
Luke Miels
CEO | Chief Executive Officer | - | 01/01/2026 |
Julie Brown
DFI | Director of Finance/CFO | 64 | 01/05/2023 |
| Chief Tech/Sci/R&D Officer | - | 01/12/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Luke Miels
BRD | Director/Board Member | - | 06/05/2026 |
Hal Barron
BRD | Director/Board Member | 64 | 01/01/2018 |
Jonathan Symonds
CHM | Chairman | 68 | 01/09/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.77% | -3.59% | - | - | 103B | |
| +0.53% | +4.82% | +91.77% | +127.92% | 1,083B | |
| +0.41% | +1.41% | +51.19% | +50.61% | 626B | |
| -0.66% | +1.27% | +25.52% | +63.74% | 442B | |
| -0.92% | +0.22% | +48.34% | +38.00% | 363B | |
| -1.32% | -0.21% | +29.07% | +36.60% | 295B | |
| -1.20% | -2.78% | +5.56% | +5.29% | 248B | |
| +0.76% | +2.48% | +46.66% | +60.15% | 224B | |
| -2.51% | +1.77% | -6.55% | -51.64% | 210B | |
| +0.84% | +3.88% | +14.04% | +71.41% | 168B | |
| Average | -0.86% | +2.88% | +33.95% | +44.68% | 406.57B | |
| Weighted average by Cap. | -0.31% | +4.29% | +49.64% | +65.31% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 33.95B 45.86B 39.73B 37.23B 63.83B 4,374B 64.81B 438B 171B 2,190B 172B 168B 7,303B | 35.6B 48.07B 41.65B 39.03B 66.92B 4,585B 67.95B 459B 179B 2,296B 181B 177B 7,656B |
| Net income | 5.56B 7.51B 6.51B 6.1B 10.46B 717B 10.62B 71.74B 28.04B 359B 28.21B 27.6B 1,196B | 6.53B 8.82B 7.64B 7.16B 12.28B 842B 12.47B 84.24B 32.93B 421B 33.13B 32.41B 1,405B |
| Net Debt | 19.08B 25.77B 22.33B 20.92B 35.87B 2,458B 36.42B 246B 96.18B 1,231B 96.76B 94.65B 4,104B | 16.24B 21.93B 19B 17.81B 30.53B 2,092B 31B 209B 81.86B 1,047B 82.35B 80.56B 3,493B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/08/26 | €21.73 | -4.10% | 696 |
| 11/08/26 | €22.66 | +1.12% | 800 |
| 10/08/26 | €22.41 | -1.10% | 96 |
| 07/08/26 | €22.66 | +1.75% | 0 |
| 06/08/26 | €22.27 | -1.20% | 0 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GSK Stock
- GS71 Stock
Select your edition
All financial news and data tailored to specific country editions
